Clinical study to test the effect of Shadushan Guggulu and Triphala Kwath in the management of Dyslipidemia.

A comparative clinical study to evaluate the effect of Shadushan Guggulu and Triphala kwath in the management of Medoroga w.s.r. to Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084358

Enrollment

Registered

2025-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Serum lipid profile : Serum Cholesterol - 200 to 350 mg/dl Serum Triglycerides - 150 to 350 mg/dl Serum LDL - 100 to 200 mg/dl Serum VLDL - 30 to 100 mg/dl Serum HDL - 20 to 40 mg/dl Patients willing to participate in the trial. Patients between the age group of 30-70 years of either gender will be selected for the study.

Exclusion criteria

Exclusion criteria: Patient having major illness like Type-II Diabetes mellitus, Carcinoma, advanced Renal and Liver disorders. Pregnant females and lactating mother. Patients who has completed participation in any other clinical trial during the past 6 months.

Design outcomes

Primary

Measure	Time frame
To reduce the level of S.Cholesterol level below 200mg/dl S.Triglycerides level below 150mg/dl S.LDL level below 100mg/dl Timepoint: 3 months	—

Secondary

Measure	Time frame
To assess the clinical safety of Shadushan Guggulu and Triphala Kwath in patients of Medoroga w.s.r. to Dyslipidaemia.Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Shri Devi

Rajiv Gandhi Govt.Post Graduate Ayurvedic college and Hospital Paprola(HP)

dranjana269@gmail.com9418312324

Outcome results